Open an account

Ocean Biomedical

OCEA · NASDAQ

$0.0005+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About OCEA

Ocean Biomedical, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 7 full-time employees. The company went IPO on 2021-09-15. The firm is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The firm helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). The company offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.

Employees
7
Headquarters
New York City, New York
Listed
Sep 15, 2021
Sector
Health Care
Industry
Biotechnology
Website
oceanbiomedical.com

OCEA key statistics

Market cap
116.18K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
46.20K
Volume
110
Open price
$0.0005
High today
$0.0005
Low today
$0.0005
52 Week high
$0.0059
52 Week low
$0.00

Ocean Biomedical (OCEA) at a glance

As of Oct 20, 2026, Ocean Biomedical (OCEA) shares are priced at $0.0005, giving the company a market cap of 116.18K and a price-to-earnings ratio of 0.00.

Volume so far is 110 shares, below the average of 46.20K shares a day.

Over the past year Ocean Biomedical has ranged from $0.00 to $0.0059, and now sits 8% of the way up that range.

Ocean Biomedical met or beat analyst EPS estimates in 1 of the last 3 quarters. In Q3 FY23 it reported -$0.53 per share against an estimate of -$0.153.

OCEA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 3 quarters, by 65.4% on average.

  1. Q1 FY23: reported -$0.06 per share against an estimate of -$0.1734
  2. Q2 FY23: reported -$0.39 per share against an estimate of -$0.204
  3. Q3 FY23: reported -$0.53 per share against an estimate of -$0.153

OCEA news

  • Avi Kapoor

    Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Avi Kapoor

    Dow Falls 100 Points; Coca-Cola Posts Upbeat Earnings

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company's Malaria Treatment and Prevention Platforms

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.